HMMR and neoplasm: HMMR is an independent risk factor for LUAD, and its high expression was significantly correlated with poor clinicopathological features and adverse outcomes (progression and metastasis of LAUD), whose expression may affect tumorigenic progression by altering the tumour microenvironment and playing a pivotal role in immune response regulation [52,53].